---
document_datetime: 2025-12-02 04:51:50
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/panretin.html
document_name: panretin.html
version: success
processing_time: 0.1054618
conversion_datetime: 2025-12-27 20:28:18.76711
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Panretin

[RSS](/en/individual-human-medicine.xml/65778)

##### Withdrawn

This medicine's authorisation has been withdrawn

alitretinoin Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Panretin](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 1 January 2021, the European Commission withdrew the marketing authorisation for Panretin (SRD) (alitretinoin) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Amdipharm Limited, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Panretin (SRD) was granted marketing authorisation in the EU on 11 October 2000 for treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma (KS). The marketing authorisation was initially valid for a 5-year period. It was subsequently renewed for an additional 5-year period in 2005. It was then granted unlimited validity in 2010.

The European Public Assessment Report (EPAR) for Panretin (SRD) is updated to indicate that the marketing authorisation is no longer valid.

Panretin : EPAR - Medicine overview

English (EN) (637.1 KB - PDF)

**First published:** 29/05/2007

**Last updated:** 02/07/2018

[View](/en/documents/overview/panretin-epar-medicine-overview_en.pdf)

[Other languages (22)](#file-language-dropdown-340)

български (BG) (706 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/bg/documents/overview/panretin-epar-medicine-overview_bg.pdf)

español (ES) (636.14 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/es/documents/overview/panretin-epar-medicine-overview_es.pdf)

čeština (CS) (690.6 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/cs/documents/overview/panretin-epar-medicine-overview_cs.pdf)

dansk (DA) (635.31 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/da/documents/overview/panretin-epar-medicine-overview_da.pdf)

Deutsch (DE) (635.69 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/de/documents/overview/panretin-epar-medicine-overview_de.pdf)

eesti keel (ET) (634.79 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/et/documents/overview/panretin-epar-medicine-overview_et.pdf)

ελληνικά (EL) (714.41 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/el/documents/overview/panretin-epar-medicine-overview_el.pdf)

français (FR) (636.79 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/fr/documents/overview/panretin-epar-medicine-overview_fr.pdf)

hrvatski (HR) (654.05 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/hr/documents/overview/panretin-epar-medicine-overview_hr.pdf)

italiano (IT) (635.67 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/it/documents/overview/panretin-epar-medicine-overview_it.pdf)

latviešu valoda (LV) (697.88 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/lv/documents/overview/panretin-epar-medicine-overview_lv.pdf)

lietuvių kalba (LT) (657.7 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/lt/documents/overview/panretin-epar-medicine-overview_lt.pdf)

magyar (HU) (685.93 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/hu/documents/overview/panretin-epar-medicine-overview_hu.pdf)

Malti (MT) (690.48 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/mt/documents/overview/panretin-epar-medicine-overview_mt.pdf)

Nederlands (NL) (636.07 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/nl/documents/overview/panretin-epar-medicine-overview_nl.pdf)

polski (PL) (690.71 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/pl/documents/overview/panretin-epar-medicine-overview_pl.pdf)

português (PT) (636.13 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/pt/documents/overview/panretin-epar-medicine-overview_pt.pdf)

română (RO) (663.54 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/ro/documents/overview/panretin-epar-medicine-overview_ro.pdf)

slovenčina (SK) (689.91 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/sk/documents/overview/panretin-epar-medicine-overview_sk.pdf)

slovenščina (SL) (680.88 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/sl/documents/overview/panretin-epar-medicine-overview_sl.pdf)

Suomi (FI) (635.37 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/fi/documents/overview/panretin-epar-medicine-overview_fi.pdf)

svenska (SV) (636.02 KB - PDF)

**First published:**

29/05/2007

**Last updated:**

02/07/2018

[View](/sv/documents/overview/panretin-epar-medicine-overview_sv.pdf)

## Product information

Panretin : EPAR - Product Information

English (EN) (770.77 KB - PDF)

**First published:** 17/04/2009

**Last updated:** 10/04/2019

[View](/en/documents/product-information/panretin-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-921)

български (BG) (1.36 MB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/bg/documents/product-information/panretin-epar-product-information_bg.pdf)

español (ES) (775.45 KB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/es/documents/product-information/panretin-epar-product-information_es.pdf)

čeština (CS) (1.15 MB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/cs/documents/product-information/panretin-epar-product-information_cs.pdf)

dansk (DA) (816.4 KB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/da/documents/product-information/panretin-epar-product-information_da.pdf)

Deutsch (DE) (758.96 KB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/de/documents/product-information/panretin-epar-product-information_de.pdf)

eesti keel (ET) (768.31 KB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/et/documents/product-information/panretin-epar-product-information_et.pdf)

ελληνικά (EL) (1.34 MB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/el/documents/product-information/panretin-epar-product-information_el.pdf)

français (FR) (780.97 KB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/fr/documents/product-information/panretin-epar-product-information_fr.pdf)

hrvatski (HR) (781.51 KB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/hr/documents/product-information/panretin-epar-product-information_hr.pdf)

íslenska (IS) (780.49 KB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/is/documents/product-information/panretin-epar-product-information_is.pdf)

italiano (IT) (773.44 KB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/it/documents/product-information/panretin-epar-product-information_it.pdf)

latviešu valoda (LV) (1.15 MB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/lv/documents/product-information/panretin-epar-product-information_lv.pdf)

lietuvių kalba (LT) (773.63 KB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/lt/documents/product-information/panretin-epar-product-information_lt.pdf)

magyar (HU) (1.12 MB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/hu/documents/product-information/panretin-epar-product-information_hu.pdf)

Malti (MT) (1.18 MB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/mt/documents/product-information/panretin-epar-product-information_mt.pdf)

Nederlands (NL) (782.84 KB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/nl/documents/product-information/panretin-epar-product-information_nl.pdf)

norsk (NO) (772.79 KB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/no/documents/product-information/panretin-epar-product-information_no.pdf)

polski (PL) (1.15 MB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/pl/documents/product-information/panretin-epar-product-information_pl.pdf)

português (PT) (781.79 KB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/pt/documents/product-information/panretin-epar-product-information_pt.pdf)

română (RO) (781.34 KB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/ro/documents/product-information/panretin-epar-product-information_ro.pdf)

slovenčina (SK) (1.14 MB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/sk/documents/product-information/panretin-epar-product-information_sk.pdf)

slovenščina (SL) (1.12 MB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/sl/documents/product-information/panretin-epar-product-information_sl.pdf)

Suomi (FI) (771.46 KB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/fi/documents/product-information/panretin-epar-product-information_fi.pdf)

svenska (SV) (774.04 KB - PDF)

**First published:**

17/04/2009

**Last updated:**

10/04/2019

[View](/sv/documents/product-information/panretin-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IAIN/0045 24/01/2019

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Panretin : EPAR - All Authorised presentations

English (EN) (620.96 KB - PDF)

**First published:** 26/01/2006

**Last updated:** 26/01/2006

[View](/en/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-89)

български (BG) (670.87 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/bg/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_bg.pdf)

español (ES) (621.3 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/es/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_es.pdf)

čeština (CS) (650.02 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/cs/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (622.59 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/da/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (620.46 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/de/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (621.29 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/et/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (661.55 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/el/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_el.pdf)

français (FR) (620.86 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/fr/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (619.92 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/it/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (658.79 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/lv/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (640.83 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/lt/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (657.79 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/hu/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (662.45 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/mt/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (620.27 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/nl/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_nl.pdf)

polski (PL) (660.55 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/pl/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_pl.pdf)

português (PT) (621.46 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/pt/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_pt.pdf)

română (RO) (637.34 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/ro/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (650.02 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/sk/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (645.35 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/sl/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (619.4 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/fi/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (628.43 KB - PDF)

**First published:**

26/01/2006

**Last updated:**

26/01/2006

[View](/sv/documents/all-authorised-presentations/panretin-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Panretin Active substance alitretinoin International non-proprietary name (INN) or common name alitretinoin Therapeutic area (MeSH) Sarcoma, Kaposi Anatomical therapeutic chemical (ATC) code L01XX22

### Pharmacotherapeutic group

Antineoplastic agents

### Therapeutic indication

Panretin gel is indicated for the topical treatment of cutaneous lesions in patients with acquired-immune-deficiency-syndrome (AIDS)-related Kaposi's sarcoma (KS) when:

- lesions are not ulcerated or lymphoedematous, and;
- treatment of visceral KS is not required, and;
- lesions are not responding to systemic antiretroviral therapy, and;
- radiotherapy or chemotherapy are not appropriate.

## Authorisation details

EMA product number EMEA/H/C/000279 Marketing authorisation holder

Eisai GmbH

Eisai GmbH

Marketing authorisation issued 11/10/2000 Revision 17

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Panretin : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (634.61 KB - PDF)

**First published:** 17/04/2009

**Last updated:** 10/04/2019

[View](/en/documents/procedural-steps-after/panretin-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Panretin : EPAR - Divergent position(s) - Article 31 of Directive 2001/83/EC resulting from pharmacovigilance data

English (EN) (592.54 KB - PDF)

**First published:** 02/07/2018

**Last updated:** 02/07/2018

[View](/en/documents/scientific-conclusion/panretin-epar-divergent-positions-article-31-directive-200183ec-resulting-pharmacovigilance-data_en.pdf)

Panretin-H-A-31-1446-C-000279-0037 : EPAR - Assessment Report

Adopted

Reference Number: EMA/254364/2018

English (EN) (846.85 KB - PDF)

**First published:** 02/07/2018

**Last updated:** 02/07/2018

[View](/en/documents/variation-report/panretin-h-31-1446-c-000279-0037-epar-assessment-report_en.pdf)

Panretin : EPAR - Steps taken after authorisation when a cutoff date has been used

English (EN) (648.81 KB - PDF)

**First published:** 26/01/2006

**Last updated:** 26/01/2006

[View](/en/documents/steps-after-cutoff/panretin-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf)

## Initial marketing authorisation documents

Panretin : EPAR - Procedural steps taken before authorisation

English (EN) (650.52 KB - PDF)

**First published:** 26/01/2006

**Last updated:** 26/01/2006

[View](/en/documents/procedural-steps/panretin-epar-procedural-steps-taken-authorisation_en.pdf)

Panretin : EPAR - Scientific Discussion

English (EN) (802.39 KB - PDF)

**First published:** 26/01/2006

**Last updated:** 26/01/2006

[View](/en/documents/scientific-discussion/panretin-epar-scientific-discussion_en.pdf)

#### More information on Panretin

- [Retinoid-containing medicinal products - referral](/en/medicines/human/referrals/retinoid-containing-medicinal-products)

**This page was last updated on** 11/01/2021

## Share this page

[Back to top](#main-content)